Drug Development Market Research Reports & Industry Analysis
The drug development industry is dedicated to creating and refining treatments that improve lives and combat diseases. This field is in a state of rapid transformation, driven by advances in technology, regulatory changes, and shifting patient needs. MarketResearch.com provides hundreds of drug development industry reports to allow stakeholders to understand important market trends, challenges, and opportunities with unparalleled clarity.
Drug Development Market Research and Industry Forecasts
- Our wide-ranging reports cover a variety of dynamic markets and provide drug development market size and growth forecasts.
- Additionally, our research includes pipeline assessments of clinical trial products and clinical developments, value chain analysis, price indicators, and more.
- The competitive landscape is also covered in detail, with information on market structure, key players, company overviews, product portfolios, financials, and SWOT analyses.
MarketResearch.com: Your Dedicated Partner
Designed with consultants and busy executives in mind, our reports are powerful tools for enhancing your decision-making process. Our research can help you anticipate market changes and seize emerging opportunities as the drug development industry continues to evolve. Browse our full list of drug development market research reports to get started.
Drug Development Industry Research & Market Reports
-
Global Structural Bioinformatics Market, By Product & Services (Tools, Platforms, Databases & Software), By Macromolecule (Proteins, RNA, DNA), By Application (Drug Discovery, X-ray Crystallography, NMR Spectroscopy, Others), By End User (Institutional Research v/s Industrial Research), By Region, Competition Forecast and Opportunities, 2017-2027
... By Region, Competition Forecast and Opportunities, 2017-2027 The global structural bioinformatics market is expected to grow at a significant rate during the forecast period. The market growth can be attributed to the rising demand for ... Read More
-
Caspase 7 (Apoptotic Protease Mch 3 or ICE Like Apoptotic Protease 3 or CMH 1 or CASP7 or EC 3.4.22.60) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Update Summary Caspase 7 (Apoptotic Protease Mch 3 or ICE Like Apoptotic Protease 3 or CMH 1 or CASP7 or EC 3.4.22.60) pipeline Target constitutes close to 5 molecules. Out of which approximately 4 molecules ... Read More
-
Toll Like Receptor 8 (CD288 or TLR8) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs In Development, 2022'; Toll Like Receptor 8 (CD288 or TLR8) pipeline Target constitutes close to 35 molecules. Out of which approximately 34 molecules are developed by companies and remaining by the universities/institutes. Toll Like ... Read More
-
Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase or PAH or EC 1.14.16.1) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... PAH or EC 1.14.16.1) pipeline Target constitutes close to 12 molecules. Out of which approximately 12 molecules are developed by Companies. The latest report GMDHC22040TDB - Phenylalanine 4 Hydroxylase - Drugs In Development, 2022, outlays ... Read More
-
Bromodomain Containing Protein 3 (RING3 Like Protein or BRD3) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... 3 - Drugs In Development, 2022'; Bromodomain Containing Protein 3 (RING3 Like Protein or BRD3) pipeline Target constitutes close to 10 molecules. Out of which approximately 9 molecules are developed by companies and remaining by ... Read More
-
Alpha L-Iduronidase (IDUA or EC 3.2.1.76) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... 2022'; Alpha L-Iduronidase (IDUA or EC 3.2.1.76) pipeline Target constitutes close to 14 molecules. Out of which approximately 13 molecules are developed by companies and remaining by the universities/institutes. Alpha L-Iduronidase (IDUA or EC 3.2.1.76) ... Read More
-
Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... FGFR4 or EC 2.7.10.1) pipeline Target constitutes close to 35 molecules. Out of which approximately 32 molecules are developed by companies and remaining by the universities/institutes. The latest report Fibroblast Growth Factor Receptor 4 - ... Read More
-
Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... 1 or JAK1 or EC 2.7.10.2) pipeline Target constitutes close to 53 molecules. Out of which approximately 53 molecules are developed by companies. The latest report Tyrosine Protein Kinase JAK1 - Drugs In Development, 2022, ... Read More
-
N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Sulphamidase or SGSH or EC 3.10.1.1) - N-sulphoglucosamine sulphohydrolase is an enzyme encoded by the SGSH gene. This enzyme is involved in the lysosomal degradation of heparan sulfate. Mutations in this gene are associated with ... Read More
-
Human Cytomegalovirus Envelope Glycoprotein B (gB) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... molecules. Out of which approximately 11 molecules are developed by Companies. The latest report Human Cytomegalovirus Envelope Glycoprotein B - Drugs In Development, 2022, outlays comprehensive information on the Human Cytomegalovirus Envelope Glycoprotein B (gB) ... Read More
-
Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 2.7.11.1) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Mutated or ATM or EC 2.7.11.1) - Serine Protein Kinase ATM is a serine/threonine protein kinase. It activates checkpoint signaling upon double strand breaks (DSBs), apoptosis and genotoxic stresses such as ionizing ultraviolet A light ... Read More
-
Apoptosis Regulator BAX (Bcl 2 Like Protein 4 or BCL2L4 or BAX) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Protein 4 or BCL2L4 or BAX) pipeline Target constitutes close to 8 molecules. Out of which approximately 4 molecules are developed by companies and remaining by the universities/institutes. The latest report Apoptosis Regulator BAX - ... Read More
-
Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Deacetylase 4 - Drugs In Development, 2022'; Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) pipeline Target constitutes close to 6 molecules. Out of which approximately 4 molecules are developed by companies ... Read More
-
Toll Like Receptor 3 (CD283 or TLR3) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... (TLR3) is a protein encoded by the TLR3 gene. It controls host immune response against pathogens through recognition of molecular patterns specific to microorganisms. TLR3 is a nucleotide-sensing TLR which is activated by double-stranded RNA, ... Read More
-
Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... 2 or JAK2 or EC 2.7.10.2) - Janus kinase 2 is a non-receptor tyrosine kinase. It is involved in various processes such as cell growth, development, differentiation, or histone modifications. It mediates essential signaling events ... Read More
-
Protein Kinase C Theta Type (nPKC Theta or PRKCQ or EC 2.7.11.13) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... 'Protein Kinase C Theta Type - Drugs In Development, 2022'; Protein Kinase C Theta Type (nPKC Theta or PRKCQ or EC 2.7.11.13) pipeline Target constitutes close to 7 molecules. Out of which approximately 5 molecules ... Read More
-
Bromodomain Containing Protein 2 (Really Interesting New Gene 3 Protein or O27.1.1 or BRD2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... (Really Interesting New Gene 3 Protein or O27.1.1 or BRD2) - Bromodomain-containing protein 2 is a protein that is encoded by the BRD2 gene. It plays a role in spermatogenesis. It plays a role in ... Read More
-
Global Recombinant Proteins Market Size study, By Product (Antibodies, Hormones, Growth Factors, Enzyme, Cytokines, Others), By Application (Drug Discovery & Development, Biopharmaceutical Production, Biotechnology Research, Academic Research Studies, Other Applications), By End User (Pharmaceutical & Biopharmaceutical Companies, Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users), and Regional Forecasts 2022-2028
... Biopharmaceutical Companies, Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users), and Regional Forecasts 2022-2028 Global Recombinant Proteins Market is valued approximately USD 910 million in 2021 and is anticipated to grow with ... Read More
-
Antiviral Drugs Market Size By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors), By Indication (Influenza, HIV AIDS, Hepatitis, Herpes Simplex Virus [HSV], Coronavirus Infection), By Type (Branded, Generic), By Age Group (Pediatric, Adult, Geriatric), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2028
... Group (Pediatric, Adult, Geriatric), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2028 The antiviral drugs market is slated to witness notable expansion through ... Read More
-
Global Genomics Market Size study, By Product & Service (Systems & Software, Consumables, Services), By Technology (Sequencing, PCR, Nucleic Acid Extraction And Purification, Microarray, Other Technologies), By Application (Drug Discovery And Development, Diagnostics, Agriculture And Animal Research, Other Applications), By End-User (Hospitals & Clinics, Research Centers And Academic & Government Institutes,, Pharmaceutical & Biotechnology Companies, Other End Users), and Regional Forecasts 2022-2028
... Animal Research, Other Applications), By End-User (Hospitals & Clinics, Research Centers And Academic & Government Institutes,, Pharmaceutical & Biotechnology Companies, Other End Users), and Regional Forecasts 2022-2028 Global Genomics Market is valued approximately USD 22.7 ... Read More
-
Global Stem Cell Assay Market Size study, By Type (Viability/Cytotoxicity, Isolation & Purification, Cell Identification, Proliferation, Differentiation, Function, Apoptosis), By Cell Type (Adult Stem Cells, Human embryonic stem cells (hESCs)), By Product & Service (Instruments, Kits, Services), By Application (Regenerative Medicine & Therapy Development, Drug Discovery & Development, Clinical Research), By End User (Biopharmaceutical & Biotechnology Companies, Research Institutes), and Regional Forecasts 2022-2028
... Kits, Services), By Application (Regenerative Medicine & Therapy Development, Drug Discovery & Development, Clinical Research), By End User (Biopharmaceutical & Biotechnology Companies, Research Institutes), and Regional Forecasts 2022-2028 Global Stem Cell Assay Market is valued ... Read More
-
Global RNA Analysis/ Transcriptomics Market Size study, By Product (Reagents/Consumables, Instruments, Software, Services), By Technology (Microarrays, Sequencing, Polymerase Chain Reaction, RNA Interference), By Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics, Comparative Transcriptomics), By End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals, Contract Research Organizations), and Regional Forecasts 2022-2028
... & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals, Contract Research Organizations), and Regional Forecasts 2022-2028Global RNA Analysis/ Transcriptomics Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy ... Read More
-
Global Research Antibodies & Reagents Market Size study, By Product (Reagent, Antibodies), By Technology (Western Blotting, Flow Cytometry, Enzyme-linked immunosorbent assay (ELISA), Immunohistochemistry, Immunofluorescence, Immunoprecipitation, Other Technologies), By Application (Proteomics, Drug Development, Genomics), By End User (Pharmaceutical & Biotechnologies Industries, Academic & Research Institutions, Contract Research Organizations), and Regional Forecasts 2022-2028
... User (Pharmaceutical & Biotechnologies Industries, Academic & Research Institutions, Contract Research Organizations), and Regional Forecasts 2022-2028Global Research Antibodies & Reagents Market is valued approximately USD 10.78 billion in 2021 and is anticipated to grow with ... Read More
-
Contract Research Organization (CROs) Services Market by Type (Early phase, Clinical, Lab, Consulting), Therapeutic Area (Oncology, Infectious Disease, Neurology, Immunology, Hematology, Vaccines), End User - Global Forecast to 2027
... estimated to grow at a CAGR of 11.0% during the forecast period. Growth in the CRO services market can mainly be attributed to factors such as the increasing investment in pharmaceutical R&D, rising number of ... Read More
-
United States Drug Discovery Market Forecast 2022-2028
... drug discovery and development markets with the presence of several industry players. MARKET INSIGHTS In the United States, cancer and heart disease have been leading death causes for over a decade. Also, the rising prevalence ... Read More
Research Assistance
